Testing a new ECG device with standard 12-lead recording
Part of Heart & circulation clinical trials.
This trial tests a new device (Sansa) by comparing it to a standard 12-lead ECG. It may help improve heart monitoring technology.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You need to be able to read and sign a consent form.
- You must be willing to have both the Sansa and a standard 12-lead ECG at the same time.
- You cannot have chest deformities (like significant scars or a sunken chest) that would prevent the device from sticking properly.
- You cannot have broken or irritated skin where the sensors would go.
- You must not have had bad reactions to medical tape or adhesives before.
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a connected watch (like a smartwatch) can accurately record your heart's electrical activity (an ECG) during a hospital stay or clinic visit. If it works well, it could make checking your heart easier and more convenient.
This study checks whether a wearable ECG patch can correctly record heart electrical signals and help identify abnormal rhythms (arrhythmias) in children. If it works well, it could make future heart rhythm monitoring more accurate for pediatric patients who need regular Holter (long ECG) monitoring.
This trial tests a wearable heart monitor (ECG) to see how well it works and stays accurate for patients in the hospital. It may help you if you need continuous heart monitoring without being tethered to a traditional machine.
This trial is testing a new handheld ECG device to see if it works well for patients with known heart conditions or symptoms that might be heart-related. If you qualify, using this simple device could help monitor your heart health more easily.
This study is testing a new, simpler ECG device (with only 4 sticky patches) against the standard 10-patch ECG. It's for people with heart conditions who are either in the hospital or visiting a cardiologist, and aims to see if the new device is easier to use and still gives a clear reading.
This trial is testing a new algorithm that uses a simple, one-lead ECG (heart tracing) to measure how fast electrical signals travel through the heart. Researchers want to see if the algorithm works well in people whose heart intervals are slightly outside the normal range, which may help doctors better monitor heart conditions.
Hear when a new Arrhythmias, Cardiac trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.